Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Ion Channel Expression and Characterization in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes

Background. Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are providing new possibilities for the biological study, cell therapies, and drug discovery. However, the ion channel expression and functions as well as regulations in hiPSC-CMs still need to be fully characterized....

Full description

Bibliographic Details
Main Authors:	Zhihan Zhao, Huan Lan, Ibrahim El-Battrawy, Xin Li, Fanis Buljubasic, Katherine Sattler, Gökhan Yücel, Siegfried Lang, Malte Tiburcy, Wolfram-Hubertus Zimmermann, Lukas Cyganek, Jochen Utikal, Thomas Wieland, Martin Borggrefe, Xiao-Bo Zhou, Ibrahim Akin
Format:	Article
Language:	English
Published:	Hindawi Limited 2018-01-01
Series:	Stem Cells International
Online Access:	http://dx.doi.org/10.1155/2018/6067096

Similar Items

Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
by: Gökhan Yücel, et al.
Published: (2017-06-01)

Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
by: Ibrahim El-Battrawy, et al.
Published: (2016-01-01)

TRPV1 activation and internalization is part of the LPS-induced inflammation in human iPSC-derived cardiomyocytes
by: Katherine Sattler, et al.
Published: (2021-07-01)

Studying Brugada Syndrome With an SCN1B Variants in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
by: Ibrahim El-Battrawy, et al.
Published: (2019-11-01)

Nucleoside Diphosphate Kinase B Contributes to Arrhythmogenesis in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes from a Patient with Arrhythmogenic Right Ventricular Cardiomyopathy
by: Fanis Buljubasic, et al.
Published: (2020-02-01)

Ionic Mechanisms of Disopyramide Prolonging Action Potential Duration in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Huan Lan, et al.
Published: (2020-10-01)

Effects of Antiarrhythmic Drugs on hERG Gating in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes From a Patient With Short QT Syndrome Type 1
by: Mengying Huang, et al.
Published: (2021-05-01)

Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression
by: Eric Schoger, et al.
Published: (2021-08-01)

Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation
by: Eric Schoger, et al.
Published: (2021-10-01)

Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation
by: Eric Schoger, et al.
Published: (2020-10-01)

Lights on for HIF-1α: Genetically Enhanced Mouse Cardiomyocytes for Heart Tissue Imaging
by: Amke R. Hesse, et al.
Published: (2014-07-01)

Generation of Engineered Human Myocardium in a Multi-well Format
by: Malte Tiburcy, et al.
Published: (2020-06-01)

Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress
by: Konstantinos Giannakopoulos, et al.
Published: (2017-04-01)

Corrigendum: Comparison and Outcome Analysis of Patients with Takotsubo Cardiomyopathy Triggered by Emotional Stress or Physical Stress
by: Konstantinos Giannakopoulos, et al.
Published: (2017-06-01)

Subtype-Directed Differentiation of Human iPSCs into Atrial and Ventricular Cardiomyocytes
by: Mandy Kleinsorge, et al.
Published: (2020-06-01)

Impact of Antiarrhythmic Drugs on the Outcome of Short QT Syndrome
by: Ibrahim El-Battrawy, et al.
Published: (2019-08-01)

IP3R-Mediated Compensatory Mechanism for Calcium Handling in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes With Cardiac Ryanodine Receptor Deficiency
by: Xiaojing Luo, et al.
Published: (2020-08-01)

The Use of Beta Blockers in Takotsubo Syndrome as Compared to Acute Coronary Syndrome
by: Marvin Kummer, et al.
Published: (2020-05-01)

Immunological Properties of Murine Parthenogenetic Stem Cell-Derived Cardiomyocytes and Engineered Heart Muscle
by: Michael Didié, et al.
Published: (2017-08-01)

Differences in Short QT Syndrome Subtypes: A Systematic Literature Review and Pooled Analysis
by: Laura S. Raschwitz, et al.
Published: (2020-01-01)

Co-culture of induced pluripotent stem cells with cardiomyocytes is sufficient to promote their differentiation into cardiomyocytes.
by: Axel J Chu, et al.
Published: (2020-01-01)

Impact of Sacubitril/Valsartan on the Long-Term Incidence of Ventricular Arrhythmias in Chronic Heart Failure Patients
by: Ibrahim El-Battrawy, et al.
Published: (2019-10-01)

Differentation and maturation of pluripotent stem cell-derived cardiomyocytes
by: Kolker, Ljudmila
Published: (2013)

Clinical outcomes associated with catecholamine use in patients diagnosed with Takotsubo cardiomyopathy
by: Uzair Ansari, et al.
Published: (2018-03-01)

Comparison of Non-human Primate versus Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Treatment of Myocardial Infarction
by: Xin Zhao, et al.
Published: (2018-02-01)

Cardiac engraftment of genetically-selected parthenogenetic stem cell-derived cardiomyocytes.
by: Tao Yang, et al.
Published: (2015-01-01)

Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study
by: Michael Behnes, et al.
Published: (2015-01-01)

Design and Rationale of the Femoral Closure versus Radial Compression Devices Related to Percutaneous Coronary Interventions (FERARI) Study
by: Michael Behnes, et al.
Published: (2015-11-01)

Long-Term Follow-Up of Patients with Catecholaminergic Polymorphic Ventricular Arrhythmia
by: Michael Veith, et al.
Published: (2020-03-01)

Impact of Chronobiological Variation in Takotsubo Syndrome: Prognosis and Outcome
by: Ibrahim El-Battrawy, et al.
Published: (2021-08-01)

Mitochondrial Maturation in Human Pluripotent Stem Cell Derived Cardiomyocytes
by: Dao-Fu Dai, et al.
Published: (2017-01-01)

Atomic force mechanobiology of pluripotent stem cell-derived cardiomyocytes.
by: Jianwei Liu, et al.
Published: (2012-01-01)

Directed Differentiation of Zebrafish Pluripotent Embryonic Cells to Functional Cardiomyocytes
by: Yao Xiao, et al.
Published: (2016-09-01)

Expansion Culture of Human Pluripotent Stem Cells and Production of Cardiomyocytes
by: Minh Nguyen Tuyet Le, et al.
Published: (2019-05-01)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
by: Guilherme Visconde Brasil, et al.
Published: (2020-07-01)

Induced pluripotent stem cell derived cardiomyocytes as models for cardiac arrhythmias
by: Maaike eHoekstra, et al.
Published: (2012-08-01)

Calcium handling in human induced pluripotent stem cell derived cardiomyocytes.
by: Ilanit Itzhaki, et al.
Published: (2011-01-01)

Human Pluripotent Stem Cell-Derived Cardiomyocytes as Research and Therapeutic Tools
by: Ivana Acimovic, et al.
Published: (2014-01-01)

Bioengineering Approaches to Mature Human Pluripotent Stem Cell-Derived Cardiomyocytes
by: Xuetao Sun, et al.
Published: (2017-03-01)

Calcium signaling in human pluripotent stem cell-derived ventricular cardiomyocytes
by: Li, Sen, et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_58ge0cas4p8ec2eimp8jn1eohn